Related Experiment Video
Updated: May 10, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy
Larisa Păduraru1, Alina-Diana Panainte1, Cătălina-Anișoara Peptu2
1Department of Analytical Chemistry, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy from Iasi, 16th Universitatii Street, 700116 Iasi, Romania.
Abstract:
Despite improvements in therapeutic approaches like immunotherapy and gene therapy, cancer still remains a serious threat to world health due to its high incidence and mortality rates. Limitations of conventional therapy include suboptimal targeting, multidrug resistance, and systemic toxicity. A major challenge in current oncology therapies is the development of new delivery methods for antineoplastic drugs that act directly on target. One approach involves the complexation of antitumor drugs with cyclodextrins (CDs) and chitosan (CS) as an attempt to counteract their primary limitations: low water solubility and bioavailability, diminished in vitro and in vivo stability, and high dose-dependent toxicity. All those drawbacks may potentially exclude some therapeutic candidates from clinical trials, thus their integration into smart delivery systems or drug-targeting technologies must be implemented. We intended to overview new drug delivery systems based on chitosan or cyclodextrins with regard to the current diagnosis and cancer management. This narrative review encompasses full-length articles published in English between 2019 and 2025 (including online ahead of print versions) in PubMed-indexed journals, focusing on recent research on the encapsulation of diverse antitumor drugs within those nanosystems that exhibit responsiveness to various stimuli such as pH, redox potential, and folate receptor levels, thereby enhancing the release of bioactive compounds at tumor sites. The majority of the cited references focus on the most notable research, studies of novel applications, and scientific advancements in the field of nanostructures and functional materials employed in oncological therapies over the last six years. Certainly, there are additional stimuli with research potential that can facilitate the drug's release upon activation, such as reactive oxygen species (ROS), various enzymes, ATP level, or hypoxia; however, our review exclusively addresses the aforementioned stimuli presented in a comprehensive manner.
Insights
Novel nanodelivery systems using cyclodextrins (CDs) and chitosan (CS) enhance antitumor drug efficacy. These smart systems target cancer sites by responding to stimuli like pH, improving drug delivery and reducing toxicity.
Area of Science:
- Oncology
- Materials Science
- Nanotechnology
Background:
- Conventional cancer therapies face limitations including poor targeting, drug resistance, and toxicity.
- Developing advanced drug delivery systems is crucial for improving cancer treatment outcomes.
- Cyclodextrins (CDs) and chitosan (CS) offer potential for creating effective nanocarriers for antineoplastic drugs.
Purpose of the Study:
- To review recent advancements in drug delivery systems utilizing chitosan or cyclodextrins for cancer management.
- To highlight nanocarriers responsive to tumor microenvironment stimuli for targeted drug release.
- To provide an overview of smart nanostructures in oncological therapies.
Main Methods:
- Narrative review of English-language articles published between 2019 and 2025 in PubMed-indexed journals.
- Focus on research involving encapsulation of antitumor drugs within chitosan or cyclodextrin-based nanosystems.
- Analysis of stimuli-responsive drug release mechanisms (pH, redox, folate receptors).
Main Results:
- Chitosan and cyclodextrin nanocarriers show promise in overcoming limitations of conventional chemotherapy.
- Stimuli-responsive nanosystems enhance targeted delivery and release of anticancer drugs at tumor sites.
- Recent research demonstrates significant advancements in nanostructures for cancer therapy.
Conclusions:
- Smart drug delivery systems based on CDs and CS are vital for improving cancer treatment efficacy.
- Targeted drug release mechanisms enhance therapeutic outcomes and minimize systemic toxicity.
- Continued research into nanocarriers holds significant potential for future oncology therapies.
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drugs that Stabilize Microtubules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

